Press Release: Addex Reports Q1 2021 Financial -2-

" "plan," "anticipate," "intend," "believe," "estimate," "predict,"

"project," "potential," "continue," "target" and similar expressions are

intended to identify forward-looking statements, although not all

forward-looking statements contain these identifying words. Any

forward-looking statements in this press release, are based on

management's current expectations and beliefs and are subject to a

number of risks, uncertainties and important factors that may cause

actual events or results to differ materially from those expressed or

implied by any forward-looking statements contained in this press

release, including, without limitation, uncertainties related to market

conditions. These and other risks and uncertainties are described in the

Company's Annual Report on Form 20-F filed with the SEC on March 11,

2021, as well as market conditions and regulatory review.

Any forward-looking statements contained in this press release represent

Addex Therapeutics' views only as of the date hereof and should not be

relied upon as representing its views as of any subsequent date. Addex

Therapeutics explicitly disclaims any obligation to update any

forward-looking statements, except as required by law.

(END) Dow Jones Newswires

May 05, 2021 01:00 ET (05:00 GMT)